Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1030 | 1030 | 1095 | 1270 | 1311 | 1766 |
Fund Return | 2.96% | 2.96% | 9.54% | 8.29% | 5.56% | 5.85% |
Place in category | 436 | 436 | 106 | 128 | 115 | 63 |
% in Category | 68 | 68 | 16 | 28 | 28 | 19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Z Fun | 6.59B | 2.92 | 8.15 | 5.79 | ||
Royal London European Growth Fund C | 2.51B | 5.97 | 9.53 | 8.20 | ||
Royal London US Tracker Z Fund Accu | 1.21B | 10.62 | 13.71 | 15.53 | ||
Royal London UK Equity Income A | 1.19B | 3.05 | 9.22 | 5.83 | ||
Royal London UK Equity Income Fund | 1.19B | 3.16 | 9.66 | 6.47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 13.61B | 4.02 | 7.99 | 5.79 | ||
All Share Index Unit Trust Income | 13.61B | -0.70 | 7.89 | - | ||
VG UK Plus GBP Accumulation | 13.61B | -0.70 | 7.91 | - | ||
VG UK Institutional Plus GBP Income | 13.61B | -0.69 | 7.90 | - | ||
UK Equity Tracker Fund D Acc | 11.33B | 2.82 | 7.88 | 5.79 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.75 | 33.88 | -0.10% | |
AstraZeneca | GB0009895292 | 6.39 | 11,268.0 | +0.16% | |
ICF FTSE 100 IDX FUT Mar24 | GB00KHK64W72 | 5.11 | - | - | |
HSBC | GB0005405286 | 5.08 | 667.70 | +0.18% | |
Unilever | GB00B10RZP78 | 4.17 | 44.98 | -0.16% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review